MIND Prize
The MIND Prize funds innovative neuroscience research to advance understanding and treatment of neurodegenerative diseases through interdisciplinary collaboration and new technologies.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years; up to 10% indirect costs included)
Summary: Supports innovative early-to-mid-career researchers advancing fundamental and translational neuroscience to combat neurodegenerative diseases through interdisciplinary collaboration.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
Description
The MIND (Maximizing Innovation in Neuroscience Discovery) Prize, established by The Pershing Square Foundation, funds pioneering research aimed at revolutionizing our understanding and treatment of neurodegenerative diseases (NDDs) such as Alzheimer’s Disease and Dementia. The prize empowers early-to-mid-career investigators to challenge traditional paradigms in NDD research, catalyzing interdisciplinary collaborations across academic departments and institutions. Supported projects may involve the development of novel tools, techniques, and technologies for brain mapping and analysis, as well as bold therapeutic approaches. Research domains include neurobiology, brain imaging, machine learning, drug delivery, and synthetic biology. In addition to financial support, recipients join a unique network of researchers, benefit from facilitated partnerships, networking opportunities with industry, annual retreats, and opportunities to present at major conferences and events.
